Tirzepatide 10mg Kit

Description

Tirzepatide is a synthetic, lipidated 39-amino-acid peptide designed for research involving incretin biology and dual receptor pharmacology. It acts as an agonist at both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R), two class B G protein-coupled receptors involved in metabolic signaling pathways.

The peptide contains a modified amino acid sequence based primarily on the GIP peptide framework, with structural features that support interaction with both GIPR and GLP-1R. A C20 fatty diacid moiety is covalently attached to a lysine side chain through a linker incorporating gamma-glutamic acid and ethoxy-based spacer units. This lipidation feature is scientifically relevant for studies of peptide–protein interactions, albumin binding, molecular stability, and pharmacokinetic design principles in peptide research.

At the molecular level, tirzepatide receptor activation is associated with Gs protein coupling and intracellular cyclic adenosine monophosphate (cAMP) signaling. This makes the compound relevant for evaluating receptor selectivity, ligand bias, signal transduction, receptor internalization, and downstream pathways connected to cellular metabolic regulation. Its dual agonist profile also provides a useful reference material for comparative studies involving single- and multi-target incretin receptor ligands.

Tirzepatide is widely relevant to scientific investigations in peptide chemistry, endocrine signaling, metabolic disease research, GPCR pharmacology, and medicinal chemistry. Researchers may use it as a reference compound when examining how sequence modification, lipid conjugation, and dual-target receptor engagement influence the biological properties of peptide-based molecules.